Literature DB >> 25668756

Ligand-independent activation of aryl hydrocarbon receptor signaling in PCB3-quinone treated HaCaT human keratinocytes.

Wusheng Xiao1, Jyungmean Son1, Sabine U Vorrink1, Frederick E Domann1, Prabhat C Goswami2.   

Abstract

Aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that plays a critical role in metabolism, cell proliferation, development, carcinogenesis, and xenobiotic response. In general, dioxin-like polychlorinated biphenyls (PCBs) exhibit a ligand-dependent activation of AhR-signaling. Results from this study show that a quinone-derivative (1-(4-Chlorophenyl)-benzo-2,5-quinone; 4-ClBQ) of a non-dioxin like PCB (PCB3) also activates AhR-signaling. Treatments of HaCaT human keratinocytes with 4-ClBQ and dioxin-like PCB126 significantly increased AhR-target gene expression, CYP1A1 mRNA and protein levels. 4-ClBQ-induced increase CYP1A1 expression was associated with an increase in the nuclear translocation of AhR protein as well as an increase in the luciferase-reporter activity of a human CYP1A1 xenobiotic response element (XRE). 6,2',4'-Trimethoxyflavone (TMF), a well-characterized AhR-ligand antagonist significantly suppressed PCB126-induced increase in CYP1A1 expression, while the same treatment did not suppress 4-ClBQ-induced increase in CYP1A1 expression. However, siRNA-mediated down-regulation of AhR significantly inhibited 4-ClBQ-induced increase in CYP1A1 expression, suggesting that AhR mediates 4-ClBQ-induced increase in CYP1A1 expression. Interestingly, treatment with the antioxidant N-acetyl-l-cysteine significantly suppressed 4-ClBQ-induced increase in CYP1A1 expression. Furthermore, CYP1A1 expression also increased in cells treated with hydrogen peroxide. These results demonstrate that a ligand-independent and oxidative stress dependent pathway activates AhR-signaling in 4-ClBQ treated HaCaT cells. Because AhR signaling is believed to mediate xenobiotics response, our results may provide a mechanistic rationale for the use of antioxidants as effective countermeasure to environmental pollutant-induced adverse health effects.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AhR; CYP1A1; HaCaT cells; Polychlorinated biphenyls; Quinone

Mesh:

Substances:

Year:  2015        PMID: 25668756      PMCID: PMC4341842          DOI: 10.1016/j.toxlet.2015.02.005

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  31 in total

Review 1.  Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment.

Authors:  J P Giesy; K Kannan
Journal:  Crit Rev Toxicol       Date:  1998-11       Impact factor: 5.635

2.  Identification of catechol and hydroquinone metabolites of 4-monochlorobiphenyl.

Authors:  M R McLean; U Bauer; A R Amaro; L W Robertson
Journal:  Chem Res Toxicol       Date:  1996 Jan-Feb       Impact factor: 3.739

Review 3.  Induction of cytochrome P4501A1.

Authors:  J P Whitlock
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

4.  Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin.

Authors:  D Phelan; G M Winter; W J Rogers; J C Lam; M S Denison
Journal:  Arch Biochem Biophys       Date:  1998-09-01       Impact factor: 4.013

5.  Inhibition of intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like PCBs in mouse hepatoma cells (Hepa1c1c7): involvement of the Ah receptor.

Authors:  L H De Haan; J W Simons; A T Bos; J M Aarts; M S Denison; A Brouwer
Journal:  Toxicol Appl Pharmacol       Date:  1994-12       Impact factor: 4.219

6.  Affinities for the aryl hydrocarbon receptor, potencies as aryl hydrocarbon hydroxylase inducers and relative toxicities of polychlorinated biphenyls. A congener specific approach.

Authors:  S A Kafafi; H Y Afeefy; A H Ali; H K Said; I S Abd-Elazem; A G Kafafi
Journal:  Carcinogenesis       Date:  1993-10       Impact factor: 4.944

7.  Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.

Authors:  K M Burbach; A Poland; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Cloning of a factor required for activity of the Ah (dioxin) receptor.

Authors:  E C Hoffman; H Reyes; F F Chu; F Sander; L H Conley; B A Brooks; O Hankinson
Journal:  Science       Date:  1991-05-17       Impact factor: 47.728

9.  The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid.

Authors:  R Wanner; S Brömmer; B M Czarnetzki; T Rosenbach
Journal:  Biochem Biophys Res Commun       Date:  1995-04-17       Impact factor: 3.575

10.  Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1.

Authors:  Y Morel; R Barouki
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  5 in total

1.  Immunometabolic Endothelial Phenotypes: Integrating Inflammation and Glucose Metabolism.

Authors:  Wusheng Xiao; William M Oldham; Carmen Priolo; Arvind K Pandey; Joseph Loscalzo
Journal:  Circ Res       Date:  2021-04-23       Impact factor: 17.367

2.  The Cellular and Molecular Determinants of Naphthoquinone-Dependent Activation of the Aryl Hydrocarbon Receptor.

Authors:  Samantha C Faber; Sara Giani Tagliabue; Laura Bonati; Michael S Denison
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 3.  Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence.

Authors:  N R Coelho; A B Pimpão; J Morello; S A Pereira; M J Correia; T C Rodrigues; E C Monteiro
Journal:  J Mol Med (Berl)       Date:  2021-11-20       Impact factor: 4.599

4.  Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects.

Authors:  Judy L Bolton; Tareisha Dunlap
Journal:  Chem Res Toxicol       Date:  2016-09-29       Impact factor: 3.739

Review 5.  The Aryl Hydrocarbon Receptor: A Mediator and Potential Therapeutic Target for Ocular and Non-Ocular Neurodegenerative Diseases.

Authors:  Mayur Choudhary; Goldis Malek
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.